Abstract: A display device includes a display panel including a display area, a driving circuit area, a driving wire area, and a sealing area. The display panel includes a first substrate, a plurality of light-emitting devices disposed on the first substrate in the display area, a gate driver disposed on the first substrate in the driving circuit area and supplying a signal for driving the light-emitting device, a plurality of wires disposed on the first substrate in the driving wire area and transmitting a clock signal to the gate driver, and an organic structure disposed on the first substrate in the driving wire area, the plurality of wires include a scan clock signal wire for transmitting a scan clock signal, and a sensing clock signal wire for transmitting a sensing clock signal, and the scan clock signal wire and the sensing clock signal wire do not overlap the organic structure.

Abstract: A display device includes a first substrate. A transistor is disposed on the first substrate. A light-emitting element is connected to the transistor. An insulating layer is disposed between the transistor and the light-emitting element. A second substrate at least partially overlaps the first substrate. A color conversion layer is disposed on the second substrate. The insulating layer includes a first insulating layer and a second insulating layer. A distance between the first insulating layer and the first substrate is less than a distance between the second insulating layer and the first substrate. The first insulating layer includes a light blocking material.

Abstract: The present invention relates to stable pharmaceutical compositions comprising linaclotide or pharmaceutically acceptable salts thereof, as well as to various methods and processes for the preparation and use of the compositions.

Abstract: A display device includes a substrate including a display area and a test area adjacent to the display area, a lower electrode disposed in the display area on the substrate, a common layer disposed on the lower electrode, an upper electrode disposed on the common layer; and a test element group. The test element group includes a plurality of electrode patterns disposed in a same layer as the lower electrode and in the test area on the substrate, a test common layer disposed in a same layer as the common layer and on the electrode patterns, where a plurality of openings is defined through the test common layer to expose a part of each of the electrode patterns, and an electrode layer disposed in a same layer as the upper electrode, on the test common layer, and in contact with the electrode patterns through the openings.

Abstract: An organic light emitting display apparatus includes a base layer, a circuit element layer, a display element layer, an encapsulation layer, and a sealing member. The circuit element layer includes a power supply line on the base layer and an auxiliary power supply pattern on and connected to the power supply line. The display element layer includes a first electrode, a light emitting layer, and a second electrode, which are sequentially stacked on the circuit element layer. The second electrode is electrically connected to the auxiliary power supply pattern. The sealing member is between the circuit element layer and the encapsulation layer to overlap with the auxiliary power supply pattern when viewed in a plan view.

Abstract: The present invention relates to delayed release pharmaceutical compositions comprising linaclotide or pharmaceutically acceptable salts thereof, as well as to various methods and processes for the preparation and use of the compositions.

Abstract: A display panel includes: a display substrate having a display area, and a pad area disposed on at least one side of thereof; and a plurality of pad groups arranged on the pad area in a first direction and including: a first pad group having a plurality of first pads, at least some of the plurality of first pads have a first inclination with respect to a reference line extending in a second direction different from the first direction, and the plurality of first pads being spaced from each other at a first pitch; and a second pad group having a plurality of second pads, at least some of the plurality of second pads having a different second inclination with respect to the reference line, and the plurality of second pads being spaced from each other at a second pitch different from the first pitch.

Abstract: A display device includes a substrate including a display area in which a plurality of pixels is disposed, and a non-display area in a peripheral area of the display area; an insulating layer disposed on the substrate; a metal wiring disposed on the substrate; and a plurality of dummy patterns disposed in the non-display area of the substrate. The plurality of dummy patterns includes a plurality of first patterns including an insulating material and a plurality of second patterns including a metal material.

Abstract: The present invention relates to stable pharmaceutical compositions comprising linaclotide or pharmaceutically acceptable salts thereof, as well as to various methods and processes for the preparation and use of the compositions.

Abstract: A display device includes a display panel including a display area, a driving circuit area, a driving wire area, and a sealing area. The display panel includes a first substrate, a plurality of light-emitting devices disposed on the first substrate in the display area, a gate driver disposed on the first substrate in the driving circuit area and supplying a signal for driving the light-emitting device, a plurality of wires disposed on the first substrate in the driving wire area and transmitting a clock signal to the gate driver, and an organic structure disposed on the first substrate in the driving wire area, the plurality of wires include a scan clock signal wire for transmitting a scan clock signal, and a sensing clock signal wire for transmitting a sensing clock signal, and the scan clock signal wire and the sensing clock signal wire do not overlap the organic structure.

Abstract: An organic light emitting display apparatus includes a base layer, a circuit element layer, a display element layer, an encapsulation layer, and a sealing member. The circuit element layer includes a power supply line on the base layer and an auxiliary power supply pattern on and connected to the power supply line. The display element layer includes a first electrode, a light emitting layer, and a second electrode, which are sequentially stacked on the circuit element layer. The second electrode is electrically connected to the auxiliary power supply pattern. The sealing member is between the circuit element layer and the encapsulation layer to overlap with the auxiliary power supply pattern when viewed in a plan view.

Abstract: Solid, stable formulations of linaclotide suitable for oral administration are described herein as are methods for preparing such formulations. The formulations described herein contain a polypeptide consisting of the amino acid sequence Cys Cys Glu Tyr Cys Cys Asn Pro Ala Cys Thr Gly Cys Tyr (“linaclotide”; SEQ ID NO:1) or a pharmaceutically acceptable salt thereof. The linaclotide formulations described herein are stable and have a sufficient shelf life for manufacturing, storing and distributing the drug.

Abstract: A display device includes a substrate; a display area and a non-display area on the substrate, where a plurality of pixels is disposed in the display area, and where the non-display area is in a peripheral area of the display area; an insulating layer disposed on the substrate; a metal wiring disposed on the substrate; and a plurality of dummy patterns disposed in the non-display area. The plurality of dummy patterns includes a plurality of first patterns including an insulating material and a plurality of second patterns including a metal material.

Abstract: A display device may include a display unit disposed on a substrate and a mirror substrate facing the substrate with respect to the display unit. The mirror substrate may include a first mirror layer extending continuously on a surface of a transparent substrate and a plurality of mirror patterns on the first mirror layer. The first mirror layer is formed on both a region in which the plurality of mirror patterns are formed and a region in which the plurality of mirror patterns are not formed. External light is incident to and reflected by the first mirror layer, thus reducing an image haze and enhancing a display quality of the display device. In addition, the first mirror layer and the plurality of mirror patterns may be formed by using a single halftone mask to simplify the manufacturing process and increase a productivity of the mirror substrate.

Abstract: A temperature adjusting device includes a first member and a flow path. The first member has thereon a first surface as a temperature control target. The flow path is formed within the first member along the first surface. A first end of the flow path serves as an inlet opening through which a heat transfer medium is introduced and a second end of the flow path serves as an outlet opening through which the heat transfer medium is discharged. The flow path is formed such that a thermal resistance between the first surface and the flow path increases as the flow path goes from the outlet opening toward the inlet opening.

Abstract: The present invention relates to delayed release pharmaceutical compositions comprising linaclotide or pharmaceutically acceptable salts thereof, as well as to various methods and processes for the preparation and use of the compositions.

Abstract: Disclosed is a method of executing deep learning programs. The method includes generating a symbolic graph corresponding to an imperative deep learning program, dividing the imperative deep learning program into a first portion related to a deep learning computation and a second portion not related to the deep learning computation, and performing a computation on the first portion using a graph runner and simultaneously performing a computation on the second portion using a language runner.

Abstract: The present invention relates to a photoresist stripper composition for manufacturing a display, and more particularly, to an integrated photoresist stripper composition which can be used in every process for manufacturing a display. More specifically, the photoresist stripper composition for manufacturing a display according to the present invention can be applied to all of transition metals and oxide semiconductor wirings, and has an excellent ability to remove modified photoresist after a hard bake process, and implant process, and a dry etch process have been performed. In particular, the photoresist stripper composition for manufacturing a display according to the present invention exhibits a corrosion inhibitory effect that has been further specialized for copper (Cu) wiring pattern edge portions which are susceptible to corrosion following dry-etching.

Abstract: A head mounted display device is provided. The head mounted display device includes a left eye display unit which displays an image for a left eye and is disposed along a trajectory of a left eye ellipse having a first eccentricity, and a left eye lens which faces the left eye display unit and refracts the image for the left eye in a direction of a user's left eye.

Abstract: The invention provides a solid composition of the peripheral mu opioid antagonist axelopran and a combination dosage form of the mu opioid antagonist axelopran sulfate in an immediate release form and an opioid analgesic agent which may be in an extended release, sustained release, modified release, or controlled release form and methods of preparing such a combination dosage form.